0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Trabectedin Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-35E3736
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Trabectedin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Trabectedin Market Research Report 2025

Code: QYRE-Auto-35E3736
Report
September 2025
Pages:67
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Trabectedin Market

The global market for Trabectedin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Trabectedin is an antitumor chemotherapy drug sold。 It is undergoing clinical trials for the treatment of breast, prostate, and paediatric sarcomas.
North American market for Trabectedin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Trabectedin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Trabectedin in Breast Cancer Treatment is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Trabectedin include Johnson and Johnson, Xeon Biopharmaceutical Limited, BrightGene Bio-Medical, Autran, Suzhou Borui Biology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Trabectedin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Trabectedin.
The Trabectedin market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Trabectedin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Trabectedin companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Trabectedin Market Report

Report Metric Details
Report Name Trabectedin Market
Segment by Type
  • Injection Product
  • Table Product
Segment by Application
  • Breast Cancer Treatment
  • Prostate Cancer Treatment
  • Pediatric Sarcoma Treatment
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson and Johnson, Xeon Biopharmaceutical Limited, BrightGene Bio-Medical, Autran, Suzhou Borui Biology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Trabectedin company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Trabectedin Market report?

Ans: The main players in the Trabectedin Market are Johnson and Johnson, Xeon Biopharmaceutical Limited, BrightGene Bio-Medical, Autran, Suzhou Borui Biology

What are the Application segmentation covered in the Trabectedin Market report?

Ans: The Applications covered in the Trabectedin Market report are Breast Cancer Treatment, Prostate Cancer Treatment, Pediatric Sarcoma Treatment, Others

What are the Type segmentation covered in the Trabectedin Market report?

Ans: The Types covered in the Trabectedin Market report are Injection Product, Table Product

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Trabectedin Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Injection Product
1.2.3 Table Product
1.3 Market by Application
1.3.1 Global Trabectedin Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer Treatment
1.3.3 Prostate Cancer Treatment
1.3.4 Pediatric Sarcoma Treatment
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Trabectedin Market Perspective (2020-2031)
2.2 Global Trabectedin Growth Trends by Region
2.2.1 Global Trabectedin Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Trabectedin Historic Market Size by Region (2020-2025)
2.2.3 Trabectedin Forecasted Market Size by Region (2026-2031)
2.3 Trabectedin Market Dynamics
2.3.1 Trabectedin Industry Trends
2.3.2 Trabectedin Market Drivers
2.3.3 Trabectedin Market Challenges
2.3.4 Trabectedin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Trabectedin Players by Revenue
3.1.1 Global Top Trabectedin Players by Revenue (2020-2025)
3.1.2 Global Trabectedin Revenue Market Share by Players (2020-2025)
3.2 Global Trabectedin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Trabectedin Revenue
3.4 Global Trabectedin Market Concentration Ratio
3.4.1 Global Trabectedin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Trabectedin Revenue in 2024
3.5 Global Key Players of Trabectedin Head office and Area Served
3.6 Global Key Players of Trabectedin, Product and Application
3.7 Global Key Players of Trabectedin, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Trabectedin Breakdown Data by Type
4.1 Global Trabectedin Historic Market Size by Type (2020-2025)
4.2 Global Trabectedin Forecasted Market Size by Type (2026-2031)
5 Trabectedin Breakdown Data by Application
5.1 Global Trabectedin Historic Market Size by Application (2020-2025)
5.2 Global Trabectedin Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Trabectedin Market Size (2020-2031)
6.2 North America Trabectedin Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Trabectedin Market Size by Country (2020-2025)
6.4 North America Trabectedin Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Trabectedin Market Size (2020-2031)
7.2 Europe Trabectedin Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Trabectedin Market Size by Country (2020-2025)
7.4 Europe Trabectedin Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Trabectedin Market Size (2020-2031)
8.2 Asia-Pacific Trabectedin Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Trabectedin Market Size by Region (2020-2025)
8.4 Asia-Pacific Trabectedin Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Trabectedin Market Size (2020-2031)
9.2 Latin America Trabectedin Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Trabectedin Market Size by Country (2020-2025)
9.4 Latin America Trabectedin Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Trabectedin Market Size (2020-2031)
10.2 Middle East & Africa Trabectedin Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Trabectedin Market Size by Country (2020-2025)
10.4 Middle East & Africa Trabectedin Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Details
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson Trabectedin Introduction
11.1.4 Johnson and Johnson Revenue in Trabectedin Business (2020-2025)
11.1.5 Johnson and Johnson Recent Development
11.2 Xeon Biopharmaceutical Limited
11.2.1 Xeon Biopharmaceutical Limited Company Details
11.2.2 Xeon Biopharmaceutical Limited Business Overview
11.2.3 Xeon Biopharmaceutical Limited Trabectedin Introduction
11.2.4 Xeon Biopharmaceutical Limited Revenue in Trabectedin Business (2020-2025)
11.2.5 Xeon Biopharmaceutical Limited Recent Development
11.3 BrightGene Bio-Medical
11.3.1 BrightGene Bio-Medical Company Details
11.3.2 BrightGene Bio-Medical Business Overview
11.3.3 BrightGene Bio-Medical Trabectedin Introduction
11.3.4 BrightGene Bio-Medical Revenue in Trabectedin Business (2020-2025)
11.3.5 BrightGene Bio-Medical Recent Development
11.4 Autran
11.4.1 Autran Company Details
11.4.2 Autran Business Overview
11.4.3 Autran Trabectedin Introduction
11.4.4 Autran Revenue in Trabectedin Business (2020-2025)
11.4.5 Autran Recent Development
11.5 Suzhou Borui Biology
11.5.1 Suzhou Borui Biology Company Details
11.5.2 Suzhou Borui Biology Business Overview
11.5.3 Suzhou Borui Biology Trabectedin Introduction
11.5.4 Suzhou Borui Biology Revenue in Trabectedin Business (2020-2025)
11.5.5 Suzhou Borui Biology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Trabectedin Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Injection Product
 Table 3. Key Players of Table Product
 Table 4. Global Trabectedin Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Trabectedin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Trabectedin Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Trabectedin Market Share by Region (2020-2025)
 Table 8. Global Trabectedin Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Trabectedin Market Share by Region (2026-2031)
 Table 10. Trabectedin Market Trends
 Table 11. Trabectedin Market Drivers
 Table 12. Trabectedin Market Challenges
 Table 13. Trabectedin Market Restraints
 Table 14. Global Trabectedin Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Trabectedin Market Share by Players (2020-2025)
 Table 16. Global Top Trabectedin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Trabectedin as of 2024)
 Table 17. Ranking of Global Top Trabectedin Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Trabectedin Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Trabectedin, Headquarters and Area Served
 Table 20. Global Key Players of Trabectedin, Product and Application
 Table 21. Global Key Players of Trabectedin, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Trabectedin Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Trabectedin Revenue Market Share by Type (2020-2025)
 Table 25. Global Trabectedin Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Trabectedin Revenue Market Share by Type (2026-2031)
 Table 27. Global Trabectedin Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Trabectedin Revenue Market Share by Application (2020-2025)
 Table 29. Global Trabectedin Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Trabectedin Revenue Market Share by Application (2026-2031)
 Table 31. North America Trabectedin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Trabectedin Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Trabectedin Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Trabectedin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Trabectedin Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Trabectedin Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Trabectedin Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Trabectedin Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Trabectedin Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Trabectedin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Trabectedin Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Trabectedin Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Trabectedin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Trabectedin Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Trabectedin Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Johnson and Johnson Company Details
 Table 47. Johnson and Johnson Business Overview
 Table 48. Johnson and Johnson Trabectedin Product
 Table 49. Johnson and Johnson Revenue in Trabectedin Business (2020-2025) & (US$ Million)
 Table 50. Johnson and Johnson Recent Development
 Table 51. Xeon Biopharmaceutical Limited Company Details
 Table 52. Xeon Biopharmaceutical Limited Business Overview
 Table 53. Xeon Biopharmaceutical Limited Trabectedin Product
 Table 54. Xeon Biopharmaceutical Limited Revenue in Trabectedin Business (2020-2025) & (US$ Million)
 Table 55. Xeon Biopharmaceutical Limited Recent Development
 Table 56. BrightGene Bio-Medical Company Details
 Table 57. BrightGene Bio-Medical Business Overview
 Table 58. BrightGene Bio-Medical Trabectedin Product
 Table 59. BrightGene Bio-Medical Revenue in Trabectedin Business (2020-2025) & (US$ Million)
 Table 60. BrightGene Bio-Medical Recent Development
 Table 61. Autran Company Details
 Table 62. Autran Business Overview
 Table 63. Autran Trabectedin Product
 Table 64. Autran Revenue in Trabectedin Business (2020-2025) & (US$ Million)
 Table 65. Autran Recent Development
 Table 66. Suzhou Borui Biology Company Details
 Table 67. Suzhou Borui Biology Business Overview
 Table 68. Suzhou Borui Biology Trabectedin Product
 Table 69. Suzhou Borui Biology Revenue in Trabectedin Business (2020-2025) & (US$ Million)
 Table 70. Suzhou Borui Biology Recent Development
 Table 71. Research Programs/Design for This Report
 Table 72. Key Data Information from Secondary Sources
 Table 73. Key Data Information from Primary Sources
 Table 74. Authors List of This Report


List of Figures
 Figure 1. Trabectedin Picture
 Figure 2. Global Trabectedin Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Trabectedin Market Share by Type: 2024 VS 2031
 Figure 4. Injection Product Features
 Figure 5. Table Product Features
 Figure 6. Global Trabectedin Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Trabectedin Market Share by Application: 2024 VS 2031
 Figure 8. Breast Cancer Treatment Case Studies
 Figure 9. Prostate Cancer Treatment Case Studies
 Figure 10. Pediatric Sarcoma Treatment Case Studies
 Figure 11. Others Case Studies
 Figure 12. Trabectedin Report Years Considered
 Figure 13. Global Trabectedin Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Trabectedin Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Trabectedin Market Share by Region: 2024 VS 2031
 Figure 16. Global Trabectedin Market Share by Players in 2024
 Figure 17. Global Top Trabectedin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Trabectedin as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Trabectedin Revenue in 2024
 Figure 19. North America Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Trabectedin Market Share by Country (2020-2031)
 Figure 21. United States Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Trabectedin Market Share by Country (2020-2031)
 Figure 25. Germany Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Trabectedin Market Share by Region (2020-2031)
 Figure 33. China Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Trabectedin Market Share by Country (2020-2031)
 Figure 41. Mexico Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Trabectedin Market Share by Country (2020-2031)
 Figure 45. Turkey Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Trabectedin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Johnson and Johnson Revenue Growth Rate in Trabectedin Business (2020-2025)
 Figure 49. Xeon Biopharmaceutical Limited Revenue Growth Rate in Trabectedin Business (2020-2025)
 Figure 50. BrightGene Bio-Medical Revenue Growth Rate in Trabectedin Business (2020-2025)
 Figure 51. Autran Revenue Growth Rate in Trabectedin Business (2020-2025)
 Figure 52. Suzhou Borui Biology Revenue Growth Rate in Trabectedin Business (2020-2025)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS